Fibrocell Science Inc (NASDAQ:FCSC)

During the Trading Day
4.62 +0.54 / +13.24%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.48 -0.1351 / -2.92%
Volume: 1.2K
Health Technology

Company Description

Fibrocell Science, Inc. operates as a autologous cell therapy company, which focuses on developing treatments for skin and connective tissue diseases with unmet medical needs. The company has a pipeline of therapeutic and aesthetic product development programs based on the first Food and Drug Administration approved cell-based product, LAVIV™ (azficel-T), in aesthetics, all of which are based on the autologous fibroblast cell. Its clinical and pre-clinical programs include treatments for restrictive burn scars, vocal cord scars, and acne scars. Fibrocell Science was founded on September 1, 2009 and is headquartered in Exton, PA.

Contact Information

Fibrocell Science, Inc.
405 Eagleview Boulevard
Exton Pennsylvania 19341
P:(484) 713-6000
Investor Relations:
(484) 713-6133



Mutual fund holders9.86%
Individual stakeholders38.36%
Other institutional16.87%

Top Executives

David M. PernockChairman & Chief Executive Officer
Keith Alan GoldanCFO, Secretary, Treasurer & Senior Vice President
Robert James SheroffVice President-Technical Operations
John MaslowskiVice President-Scientific Affairs
Karen DonhauserVice President-Quality

To view my watchlist

Not a member yet?

Sign up now for a free account